High-Expression of Neuropilin 1 Correlates to Estrogen-Induced Epithelial-Mesenchymal Transition of Endometrial Cells in Adenomyosis

article OA: closed CC0 ⤵ 35 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-12

High-expression of neuropilin 1 in adenomyosis endometrium correlates with estrogen-induced epithelial-mesenchymal transition and enhanced cell migration.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-06 · read from full text

The paper investigates whether neuropilin 1 (NRP1) contributes to estrogen-induced epithelial-mesenchymal transition (EMT) during adenomyosis, focusing on its expression in human adenomyosis endometrium and its functional effects in endometrial cells. Using endometrial samples, the authors report that NRP1 expression is significantly increased in adenomyosis endometrium, especially in ectopic tissue, and in human endometrial cells (HEC-1-A) NRP1 overexpression drives a mesenchymal phenotype with reduced E-cadherin and occludin, increased α-SMA and N-cadherin, and enhanced migration. They further show that 17β-estradiol up-regulates NRP1 dose-dependently, an effect blocked by the estrogen receptor inhibitor raloxifene, while NRP1 knockdown suppresses E2-induced EMT and reduces Smad3 phosphorylation with restoration of Slug and Snail1 mRNA. A key limitation is the mechanistic evidence is largely derived from in vitro cell models rather than in vivo validation. This paper is centrally about endometriosis and/or adenomyosis—adenomyosis specifically—linking high NRP1 expression and estrogen-driven EMT of endometrial cells to adenomyosis pathogenesis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Epithelial-mesenchymal transition (EMT) induced by estrogen contributes to the development of adenomyosis. However, the exact underlying mechanism remains mostly obscure. We hypothesized that a transmembrane glycoprotein neuropilin 1 (NRP1) was critical in the EMT induced by estrogen, accelerating the development of adenomyosis. We firstly investigated the expression pattern of NRP1 in endometrium samples from women with adenomyosis. We found that NRP1 expression was significantly increased in the endometrium of uterine adenomyosis, especially in the ectopic endometrium. To determine the role of NRP1 in the EMT in endometrial cells, we used an NRP1 overexpression retrovirus to up-regulate the NPR1 expression in human endometrial cells (HEC-1-A). Endometrial cells infected with NRP1 retroviruses showed a high expression of NRP1 and exerted a mesenchymal phenotype, characterized by down-regulation of E-cadherin and Occludin, up-regulation of α-SMA and N-cadherin, and enhanced migration. Then, we found that 17β-estradiol (E2) up-regulated the expression of NRP1 in endometrial cells in a dose-dependent manner, which was eliminated by raloxifene, a selective estrogen receptor inhibitor. Importantly, NRP1 shRNA significantly suppressed the EMT induced by E2 in endometrial cells. And NRP1 shRNA significantly inhibited the phosphorylation of Smad3 and restored the expressions of Slug and Snail1 mRNA. Collectively, these data highlight the possible role of NRP1 in the EMT in the development of adenomyosis and provide a potential therapeutic target for adenomyosis patients.
Full text 8,963 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Epithelial-mesenchymal transition (EMT) induced by estrogen contributes to the development of adenomyosis. However, the exact underlying mechanism remains mostly obscure. We hypothesized that a transmembrane glycoprotein neuropilin 1 (NRP1) was critical in the EMT induced by estrogen, accelerating the development of adenomyosis. We firstly investigated the expression pattern of NRP1 in endometrium samples from women with adenomyosis. We found that NRP1 expression was significantly increased in the endometrium of uterine adenomyosis, especially in the ectopic endometrium. To determine the role of NRP1 in the EMT in endometrial cells, we used an NRP1 overexpression retrovirus to up-regulate the NPR1 expression in human endometrial cells (HEC-1-A). Endometrial cells infected with NRP1 retroviruses showed a high expression of NRP1 and exerted a mesenchymal phenotype, characterized by down-regulation of E-cadherin and Occludin, up-regulation of α-SMA and N-cadherin, and enhanced migration. Then, we found that 17β-estradiol (E2) up-regulated the expression of NRP1 in endometrial cells in a dose-dependent manner, which was eliminated by raloxifene, a selective estrogen receptor inhibitor. Importantly, NRP1 shRNA significantly suppressed the EMT induced by E2 in endometrial cells. And NRP1 shRNA significantly inhibited the phosphorylation of Smad3 and restored the expressions of Slug and Snail1 mRNA. Collectively, these data highlight the possible role of NRP1 in the EMT in the development of adenomyosis and provide a potential therapeutic target for adenomyosis patients. Similar content being viewed by others

References

Oh SJ, Shin JH, Kim TH, Lee HS, Yoo JY, Ahn JY, et al. Beta-catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition. J Pathol. 2013;231:210–22. Chen YJ, Li HY, Huang CH, Twu NF, Yen MS, Wang PH, et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J Pathol. 2010;222:261–70. Cheong Y, Cameron IT, Critchley HOD. Abnormal uterine bleeding. Br Med Bull. 2017;123:103–14. Bilyk O, Coatham M, Jewer M, Postovit LM. Epithelial-to-Mesenchymal transition in the female reproductive tract: from Normal functioning to disease pathology. Front Oncol. 2017;7:145. Zhou W, Peng Z, Zhang C, Liu S, Zhang Y. ILK-induced epithelial-mesenchymal transition promotes the invasive phenotype in adenomyosis. Biochem Biophys Res Commun. 2018;497:950–6. Liu X, Shen M, Qi Q, Zhang H, Guo SW. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod. 2016;31:734–49. Wang Y, Wang E, Zhang Y, Madamsetty VS, Ji B, Radisky DC, et al. Neuropilin-1 maintains dimethylarginine dimethylaminohydrolase 1 expression in endothelial cells, and contributes to protection from angiotensin II-induced hypertension. FASEB J. 2019;33:494–500. Zhu H, Jiang X, Zhou X, Dong X, Xie K, Yang C, et al. Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells. Liver Int. 2018;38:125–35. Vivekanandhan S, Mukhopadhyay D. Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-beta) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis. Semin Cancer Biol. 2018;S1004-579X:30283–3. Kiso M, Tanaka S, Saji S, Toi M, Sato F. Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network. Int J Cancer. 2018;143:2905–18. Matkar PN, Singh KK, Rudenko D, Kim YJ, Kuliszewski MA, Prud'homme GJ, et al. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:69489–506. Luo M, Hou L, Li J, Shao S, Huang S, Meng D, et al. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-kappaB and beta-catenin. Cancer Lett. 2016;373:1–11. Chu W, Song X, Yang X, Ma L, Zhu J, He M, et al. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma. PLoS One. 2014;9:e101931. Wang L, Zeng H, Wang P, Soker S, Mukhopadhyay D. Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem. 2003;278:48848–60. Vivekanandhan S, Yang L, Cao Y, Wang E, Dutta SK, Sharma AK, et al. Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesis. Sci Rep. 2017;7:12877. Huang XT, Yue SJ, Li C, Huang YH, Cheng QM, Li XH, et al. A sustained activation of pancreatic NMDARs is a novel factor of beta-cell apoptosis and dysfunction. Endocrinology. 2017;158:3900–13. Song W, He D, Chen Y, Yeh CR, Hsu I, Huang Q, et al. Targeting newly identified ERbeta/TGFbeta-1/SMAD3 signals with the FDA-approved antiestrogen Faslodex or an ERbeta selective antagonist in renal cell carcinoma. Mol Oncol. 2018;12:2055–71. Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod BioMed Online. 2017;35:592–601. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril. 2017;108:483–90 e483. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29:964–77. Yen CF, Huang SJ, Lee CL, Wang HS, Liao SK. Molecular characteristics of the endometrium in uterine Adenomyosis and its biochemical microenvironment. Reprod Sci. 2017;24:1346–61. Garcia-Solares J, Donnez J, Donnez O, Dolmans MM. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109:371–9. Xu J, Zhou J, Dai H, Liu F, Li W, Wang W, et al. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin. J Transl Med. 2018;16:169. Li G, Su Q, Liu H, Wang D, Zhang W, Lu Z, et al. Frizzled7 promotes epithelial-to-mesenchymal transition and Stemness via activating canonical Wnt/beta-catenin pathway in gastric Cancer. Int J Biol Sci. 2018;14:280–93. Huang X, Zhu H, Gao Z, Li J, Zhuang J, Dong Y, et al. Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. J Biol Chem. 2018;293:6693–706. Feng T, Wei S, Wang Y, Fu X, Shi L, Qu L, et al. Rhein ameliorates adenomyosis by inhibiting NF-kappaB and beta-catenin signaling pathway. Biomed Pharmacother. 2017;94:231–7. Yoshida S, Wada N, Hasegawa D, Miyaji H, Mitarai H, Tomokiyo A, et al. Semaphorin 3A induces Odontoblastic phenotype in dental pulp stem cells. J Dent Res. 2016;95:1282–90. Rehman M, Tamagnone L. Semaphorins in cancer: biological mechanisms and therapeutic approaches. Semin Cell Dev Biol. 2013;24:179–89. Pan Q, Chathery Y, Wu Y, Rathore N, Tong RK, Peale F, et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J Biol Chem. 2007;282:24049–56. Weekes CD, Beeram M, Tolcher AW, Papadopoulos KP, Gore L, Hegde P, et al. A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors. Investig New Drugs. 2014;32:653–60. Liu WQ, Lepelletier Y, Montes M, Borriello L, Jarray R, Grepin R, et al. NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model. Cancer Lett. 2018;414:88–98. Guo S, Li Z, Yan L, Sun Y, Feng Y. GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity. Drug Des Devel Ther. 2018;12:1621–31. Funding This study was supported by the Hunan Provincial Natural Science Foundation of China (2017JJ3483). Author information Authors and Affiliations Contributions YPL and RH conceived and designed the experiments. RH, GQP, DYB, and XQZ performed the experiments. RH, CZ, and GQP analyzed the data. YPL contributed reagents/materials/analysis tools. RH wrote the paper. YPL critically reviewed the manuscript. All authors had final approval of the submitted versions. Corresponding author Ethics declarations Conflict of Interest The authors declare that they have no conflict of interest. Rights and permissions About this article Cite this article Hu, R., Peng, GQ., Ban, DY. et al. High-Expression of Neuropilin 1 Correlates to Estrogen-Induced Epithelial-Mesenchymal Transition of Endometrial Cells in Adenomyosis. Reprod. Sci. 27, 395–403 (2020). https://doi.org/10.1007/s43032-019-00035-2 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s43032-019-00035-2

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Endometrium Epithelial-Mesenchymal Transition Estradiol Neuropilin-1 Adenomyosis Adult Antigens, CD Antigens, CD Cadherins Cadherins Cell Line Dose-Response Relationship, Drug Endometrium Endometrium Epithelial-Mesenchymal Transition Estradiol Female Humans Middle Aged

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Cited by (36)

Source provenance

europepmc
last seen: 2026-08-17T06:11:01.428247+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:17.025735+00:00
unpaywall
last seen: 2026-08-17T06:25:09.426038+00:00
License: CC0 · commercial use OK